S 717-515 repealed by No 147 of 2005, s 3 and Sch 2 item 16, effective 14 December 2005. For additional application provisions see note under Subdiv
802-A
heading.
S 717-515 formerly read:
Single entity rule for FDA credits and FDA debits
717-515
If a company is a
*
subsidiary member of a
*
consolidated group for any period, it and any other subsidiary member of the group are taken for the purposes of sections
128TA
and
128TB
of the
Income Tax Assessment Act 1936
to be parts of the
*
head company of the group, rather than separate entities, during that period.
Note 1: This has the effect that:
(a)
FDA credits and FDA debits arise under sections
128TA
and
128TB
(respectively) of the
Income Tax Assessment Act 1936
for the head company of a consolidated group but not for a subsidiary member of the group; and
(b)
the shareholdings of all members of a consolidated group are aggregated to work out whether dividends paid to a member are non-portfolio dividends for the purposes of those sections.
Note 2: Section
717-10
may also affect FDA credits and FDA debits for the head company of a consolidated group. It treats the head company as having paid and been personally liable for foreign tax on foreign income included in its assessable income if a subsidiary member of the group actually paid and was personally liable for the tax.
S 717-515 inserted by No 16 of 2003, s 3 and Sch 9 item 1, effective 24 October 2002 and applicable on and after 1 July 2002 (see sec
700-1
of the
Income Tax (Transitional Provisions) Act 1997
).